Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.

por Flavell, D. J., Boehm, D. A., Noss, A., Flavell, S. U.
Publicado 1997

Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice

por Flavell, D J, Warnes, S L, Noss, A L, Flavell, S U
Publicado 2000

Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual im...

por Flavell, D J, Boehm, D A, Noss, A, Warnes, S L, Flavell, S U
Publicado 2001

Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.

por Flavell, D. J., Flavell, S. U., Boehm, D. A., Emery, L., Noss, A., Ling, N. R., Richardson, P. R., Hardie, D., Wright, D. H.
Publicado 1995